PD-L1 expression of 742 newly diagnosed advanced respiratory and digestive system tumours in China based on SP142 assay.

被引：0
|
作者：
Chen, Yanhui
Wang, Yating
Yang, Bohang
Hu, Ying
Zeng, Hui
Zhang, Henghui
机构：
[1] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Lab Emerging Infect Dis, Beijing, Peoples R China
[2] Genecast Precis Med Technol Inst, Beijing, Peoples R China
[3] Capital Med Univ, Beijing Key Lab Emerging Infect Dis, Inst Infect Dis, Beijing Ditan Hosp, Beijing, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.e24298
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e24298
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Ventana PD-L1 (SP142) Assay
    McGill, Rachel
    Michail, Ramez
    Miller, Brianne
    Milton, Erica
    Musyoka, Agnes
    Musyoka, Rhoda
    O'Conner, Jada
    Ogunnaike, Morenike
    Omeke, Soteria
    Franklin, Gallop
    Honeywell, Marlon S.
    US PHARMACIST, 2022, 47 (10) : 42 - 44
  • [2] PD-L1 Expression in Metaplastic Breast Carcinoma Using the PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical Assays
    Grabenstetter, Anne
    Jungbluth, Achim A.
    Frosina, Denise
    Hoda, Raza
    Dos Anjos, Carlos H.
    Patil, Sujata
    Sevilimedu, Varadan
    Weigelt, Britta
    Reis-Filho, Jorge S.
    Zhang, Hong
    Traina, Tiffany
    Robson, Mark E.
    Brogi, Edi
    Wen, Hannah Y.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2021, 45 (09) : 1274 - 1281
  • [3] Development of a PD-L1 Complementary Diagnostic Immunohistochemistry Assay (SP142) for Atezolizumab
    Vennapusa, Bharathi
    Baker, Brian
    Kowanetz, Marcin
    Boone, Jennifer
    Menzl, Ina
    Bruey, Jean-Marie
    Fine, Gregg
    Mariathasan, Sanjeev
    McCaffery, Ian
    Mocci, Simonetta
    Rost, Sandra
    Smith, Dustin
    Dennis, Eslie
    Tang, Szu-Yu
    Damadzadeh, Bita
    Walker, Espen
    Hegde, Priti S.
    Williams, J. Andrew
    Koeppen, Hartmut
    Boyd, Zachary
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2019, 27 (02) : 92 - 100
  • [4] Development of a PD-L1 companion diagnostic IHC assay (SP142) for atezolizumab
    Boyd, Zachary S.
    Smith, Dustin
    Baker, Brian
    Vennapusa, Bharathi
    Koeppen, Hartmut
    Kowanetz, Marcin
    Mariathasan, Sanjeev
    Bruey, Jean-Marie
    Mackey, Howard
    Fine, Gregg
    Mocci, Simonetta
    Hegde, Priti
    Williams, J. Andrew
    McCaffery, Ian
    CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [5] PD-L1 expression in muscle invasive urothelial carcinoma: Comparison of SP142 and SP263 assay
    Gupta, Gurudutt
    Pasricha, Sunil
    Kamboj, Meenakshi
    Sharma, Anila
    Nayana, N. S.
    Durga, Garima
    Sharma, Anurag
    Rawal, Sudhir
    Meh, Anurag
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2022, 65 (04) : 839 - 843
  • [6] PD-L1 Expression in Metaplastic Breast Carcinoma (MBC) Using PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical (IHC) Assays
    Grabenstetter, Anne
    Jungbluth, Achim
    Frosina, Denise
    Hoda, Raza
    Weigelt, Britta
    Reis-Filho, Jorge
    Zhang, Hong
    Traina, Tiffany
    Robson, Mark
    Brogi, Edi
    Wen, Hannah
    LABORATORY INVESTIGATION, 2020, 100 (SUPPL 1) : 159 - 160
  • [7] PD-L1 Expression in Metaplastic Breast Carcinoma (MBC) Using PD-L1 SP142 Assay and Concordance Among PD-L1 Immunohistochemical (IHC) Assays
    Grabenstetter, Anne
    Jungbluth, Achim
    Frosina, Denise
    Hoda, Raza
    Weigelt, Britta
    Reis-Filho, Jorge
    Zhang, Hong
    Traina, Tiffany
    Robson, Mark
    Brogi, Edi
    Wen, Hannah
    MODERN PATHOLOGY, 2020, 33 (SUPPL 2) : 159 - 160
  • [8] Expression of PD-L1 using SP142 CDx in triple negative breast cancer
    Al-Jussani, Ghada N.
    Dabbagh, Tamara Z.
    Al-Rimawi, Dalia
    Sughayer, Maher A.
    ANNALS OF DIAGNOSTIC PATHOLOGY, 2021, 51
  • [9] Study on the heterogeneity of expression of PD-L1 (Ventana SP142) in breast cancer in space and time
    He, J.
    Liu, Y.
    VIRCHOWS ARCHIV, 2021, 479 (SUPPL 1) : S70 - S70
  • [10] Prevalence Study of PD-L1 SP142 Assay in Metastatic Triple-negative Breast Cancer
    Li, Yijin
    Vennapusa, Bharathi
    Chang, Ching-Wei
    Tran, David
    Nakamura, Rin
    Sumiyoshi, Teiko
    Hegde, Priti
    Molinero, Luciana
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2021, 29 (04) : 258 - 264
12345